These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6337029)

  • 21. Obesity, the sympathetic nervous system, and essential hypertension.
    Tuck ML
    Hypertension; 1992 Jan; 19(1 Suppl):I67-77. PubMed ID: 1730457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings.
    Grassi G; Trevano FQ; Dell'Oro R; Seravalle G; Mancia G
    Curr Hypertens Rep; 2019 Oct; 21(11):90. PubMed ID: 31599352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rôle of sympathetic nervous system in essential hypertension.
    Distler A; Philipp T
    Contrib Nephrol; 1980; 23():150-7. PubMed ID: 7002447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central sympathetic transmitters and hypertension.
    Henning M
    Clin Sci Mol Med Suppl; 1975 Jun; 2():195s-203s. PubMed ID: 802636
    [No Abstract]   [Full Text] [Related]  

  • 25. The sympathetic system in hypertension.
    de Champlain J
    Clin Endocrinol Metab; 1977 Nov; 6(3):633-55. PubMed ID: 22413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs five years later: clonidine.
    Lowenstein J
    Ann Intern Med; 1980 Jan; 92(1):74-7. PubMed ID: 6101302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamines and essential hypertension.
    Esler MD
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):415-38. PubMed ID: 8489485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of noradrenaline and other transmitter hormones in the pathogenesis of hypertension.
    Louis WJ; Jarrott B; Doyle AE
    Clin Sci Mol Med Suppl; 1976 Dec; 3():427s-430s. PubMed ID: 799556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe paroxysmal hypertension (pseudopheochromocytoma).
    Mann SJ
    Curr Hypertens Rep; 2008 Feb; 10(1):12-8. PubMed ID: 18367021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of heart rate for cardiovascular disease and hypertension.
    Tjugen TB; Flaa A; Kjeldsen SE
    Curr Hypertens Rep; 2010 Jun; 12(3):162-9. PubMed ID: 20431967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of clonidine on sympathetic function.
    Bravo EL
    Chest; 1983 Feb; 83(2 Suppl):369-71. PubMed ID: 6337029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonidine and the kidney.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1980; 2 Suppl 1():S47-60. PubMed ID: 6154836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The sympathetic nervous system and essential hypertension].
    Distler A
    Med Klin; 1979 Nov; 74(47):1735-41. PubMed ID: 392290
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of hypertension by reduction in sympathetic activity.
    Mathias CJ
    Hypertension; 1991 Apr; 17(4 Suppl):III69-74. PubMed ID: 2013496
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.